Eli Lilly and Company (LLY) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Eli Lilly and Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 46.76x | 65.65x | 100.04x | 55.66x | 47.19x | 26.08x |
| P/B Ratio | 36.37x | 48.99x | 48.67x | 32.64x | 29.34x | 28.63x |
| P/S Ratio | 14.81x | 15.44x | 15.36x | 12.18x | 9.30x | 6.58x |
| Profitability | ||||||
| Gross Margin | 83.8% | 81.3% | 79.2% | 76.8% | 74.2% | 77.7% |
| Operating Margin | 45.6% | 38.9% | 31.6% | 30.3% | 28.0% | 29.4% |
| Net Margin | 31.7% | 23.5% | 15.4% | 21.9% | 19.7% | 25.2% |
| EBITDA Margin | 42.9% | 33.8% | 25.1% | 30.3% | 28.4% | 36.3% |
| Liquidity | ||||||
| Current Ratio | 1.58x | 1.15x | 0.94x | 1.05x | 1.23x | 1.40x |
| Quick Ratio | 1.19x | 0.89x | 0.73x | 0.80x | 0.97x | 1.08x |
| Leverage | ||||||
| Debt/Equity | 1.60x | 2.37x | 2.34x | 1.52x | 1.88x | 2.94x |
YoY = year-over-year change. Source: FMP..